PubMed Health⌕ Search

PubMed · 16032563

Community-associated methicillin-resistant Staphylococcus aureus.

Abstract

Historically, infection with strains of methicillin-resistant Staphylococcus aureus (MRSA), which are usually multidrug-resistant, has been acquired by persons in hospitals, nursing homes, and other health care institutions. These infections are known as health care-associated MRSA infections. Community-associated MRSA (CA-MRSA) infection, which bears significant similarities to and differences from health care-associated MRSA infection, appears to be on the rise and has been described in several well-defined populations, such as children, incarcerated persons, Alaskan Natives, Native Americans, Pacific Islanders, sports participants, and military personnel. CA-MRSA infection has caused severe morbidity and death in otherwise healthy persons. Proven, reproducible strategies and programs for preventing the emergence and spread of CA-MRSA are lacking. Further surveillance and epidemiological and clinical studies on CA-MRSA infections are necessary for documenting the extent of the problem and for developing and evaluating effective prevention and control efforts.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Todd Weber. 2005-08-15. Community-associated methicillin-resistant Staphylococcus aureus.. https://doi.org/10.1086/430788

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

CTX-M: changing the face of ESBLs in Europe.

Since around 2000 - earlier in Poland and Spain and later in France and the UK - dramatic shifts have occurred in the prevalence and types of extended-spectrum beta-lactamases (ESBLs) in Europe. Before this watershed, most producers were nosocomial isolates, often Klebsiella spp. or Enterobacter spp. from specialist care units, and had mutant TEM or SHV ESBLs. Subsequently, CTX-M ESBLs have become dominant, with much greater penetration into Escherichia coli, and with many infections in 'complicated community' patients, usually with underlying disease, recent antibiotic usage, or healthcare contact. The degree of clonality among producers varies with the country, as does the enzyme type produced, with group 9 (CTX-M-9 and -14) enzymes dominant in Spain and group 1 enzymes (particularly CTX-M-3 and -15) dominant elsewhere. Irrespective of the particular enzyme, most producers are multiresistant. These changing patterns present major therapeutic and infection control challenges, with the public health intervention points unclear.

Community-Acquired Infections↗